ALX Oncology Holdings Inc.
ALXO
$2.11
-$0.07-3.21%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -116.57M | -130.02M | -134.85M | -151.16M | -171.44M |
| Total Depreciation and Amortization | 840.00K | 869.00K | 872.00K | 865.00K | 850.00K |
| Total Amortization of Deferred Charges | 271.00K | 268.00K | 265.00K | 260.00K | 257.00K |
| Total Other Non-Cash Items | 22.58M | 23.46M | 24.23M | 23.83M | 22.90M |
| Change in Net Operating Assets | -12.61M | -3.23M | -12.43M | -3.34M | 12.11M |
| Cash from Operations | -105.49M | -108.65M | -121.91M | -129.54M | -135.33M |
| Capital Expenditure | -316.00K | -359.00K | -447.00K | -535.00K | 917.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 109.15M | 87.79M | 86.70M | 36.94M | 22.61M |
| Cash from Investing | 108.84M | 87.43M | 86.26M | 36.41M | 23.53M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -978.00K | -959.00K | -827.00K | -814.00K | -567.00K |
| Issuance of Common Stock | 432.00K | 27.79M | 30.68M | 94.26M | 94.26M |
| Repurchase of Common Stock | -29.59M | -29.59M | -29.59M | -29.59M | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 30.56M | 30.56M | 30.56M | 25.80M | -4.40M |
| Cash from Financing | 422.00K | 27.80M | 30.82M | 89.66M | 89.29M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.77M | 6.57M | -4.84M | -3.48M | -22.51M |